SeekingAlpha · Mar 20, 2026
Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors
After years of technology dominance, market leadership appears to be shifting; will it last? Click here to read more.
NYSE · BIS
ProShares UltraShort Nasdaq Biotechnology
Financial Services · Asset Management
$11.46
Up+$0.25 (+2.23%)
Updated Oct 26, 2026, 9:39 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.99M
- P/E ratio
- —
- Dividend yield
- 5.24%
- 52-week range
- $7.95 – $18.50
- Volume
- 14.25K
- Avg. volume
- 13.8K
Price performance · BIS
BIS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 23, 2026
BIS closed at $11.46 after 20 trading sessions, up 2.80% for the selected period.
- Last close
- $11.46
- Period change
- +2.80%
- Period low
- $11.03
- Period high
- $12.32
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | $11.5099 | $11.56 | $11.36 | $11.4601 | 14.25K |
| Oct 22, 2026 | $11.14 | $11.41 | $10.911 | $11.2097 | 12.45K |
| Oct 21, 2026 | $10.8701 | $11.04 | $10.845 | $11.0316 | 9.59K |
| Oct 20, 2026 | $11.625 | $11.753 | $11.08 | $11.1054 | 11.84K |
| Oct 19, 2026 | $12.05 | $12.05 | $11.77 | $11.857 | 2.98K |
| Oct 16, 2026 | $11.30 | $12.1002 | $11.30 | $12.0872 | 8.61K |
| Oct 15, 2026 | $11.50 | $11.55 | $11.34 | $11.4605 | 13.5K |
| Oct 14, 2026 | $12.105 | $12.105 | $11.8965 | $11.9406 | 7.14K |
| Oct 13, 2026 | $11.975 | $12.33 | $11.87 | $12.3202 | 14.39K |
| Oct 12, 2026 | $11.61 | $11.79 | $11.58 | $11.74 | 22.52K |
| Oct 9, 2026 | $12.145 | $12.196 | $11.48 | $11.5256 | 14.19K |
| Oct 8, 2026 | $12.20 | $12.63 | $12.20 | $12.2209 | 11.18K |
| Oct 7, 2026 | $12.01 | $12.01 | $11.81 | $11.9452 | 3.12K |
| Oct 6, 2026 | $11.39 | $12.05 | $11.39 | $12.0068 | 3.4K |
| Oct 5, 2026 | $11.6501 | $11.81 | $11.435 | $11.4757 | 6.89K |
| Oct 2, 2026 | $11.6613 | $11.81 | $11.6613 | $11.71 | 4.51K |
| Oct 1, 2026 | $11.26 | $11.64 | $11.21 | $11.6355 | 41.87K |
| Sep 30, 2026 | $11.18 | $11.215 | $11.00 | $11.1635 | 9.8K |
| Sep 29, 2026 | $11.06 | $11.2886 | $11.0463 | $11.1142 | 11.35K |
| Sep 28, 2026 | $11.14 | $11.16 | $11.06 | $11.148 | 10.66K |
Latest BIS news
The latest Smart Investors Daily articles mentioning BIS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
BIS research
Overview
Company profile and research snapshot.
Company profile
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Mar 6, 2026
The Trump Administration's Affordability Plan
SeekingAlpha · Jan 22, 2026
Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize?
Healthcare stocks were rattled by US policy uncertainty in 2025. But signs of resilience have surfaced as the sector reaffirms its defensive strengths and growth potential.
SeekingAlpha · Jan 8, 2026
Healthcare Stocks In Focus: Assessing The Outlook For 2026
After a prolonged slump, investors are giving the healthcare sector a second look. TD Asset Management's Jacky He discusses potential drivers for biotech and pharmaceutical stocks in 2026.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
